Paul Knight
Stock Analyst at Keybanc
(2.37)
# 2,567
Out of 5,143 analysts
139
Total ratings
46.96%
Success rate
-1.68%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $639.45 | +17.29% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $247.78 | +41.25% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $4.89 | +206.75% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $8.58 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $124.47 | +76.75% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $10.93 | +37.24% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.62 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $69.65 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $400.42 | +14.88% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.61 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $4.41 | +81.41% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $117.75 | +23.14% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $194.66 | +115.76% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $101.62 | +126.33% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $25.98 | +27.02% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $42.15 | -14.59% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $240.08 | +29.12% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $167.93 | +31.01% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $19.16 | +93.11% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.83 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $3.33 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $138.63 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $41.03 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $12.24 | +226.80% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $224.03 | +33.91% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $239.05 | +4.58% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $105.09 | +319.64% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $158.54 | +48.86% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $82.80 | +19.57% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $13.10 | +319.85% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $43.80 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $86.54 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $153.95 | - | 5 | Oct 23, 2017 |
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $639.45
Upside: +17.29%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $247.78
Upside: +41.25%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $4.89
Upside: +206.75%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $8.58
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $124.47
Upside: +76.75%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $10.93
Upside: +37.24%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.62
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $69.65
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $400.42
Upside: +14.88%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.61
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $4.41
Upside: +81.41%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $117.75
Upside: +23.14%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $194.66
Upside: +115.76%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $101.62
Upside: +126.33%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $25.98
Upside: +27.02%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $42.15
Upside: -14.59%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $240.08
Upside: +29.12%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $167.93
Upside: +31.01%
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $19.16
Upside: +93.11%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.83
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.33
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $138.63
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $41.03
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $12.24
Upside: +226.80%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $224.03
Upside: +33.91%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $239.05
Upside: +4.58%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $105.09
Upside: +319.64%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $158.54
Upside: +48.86%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $82.80
Upside: +19.57%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $13.10
Upside: +319.85%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $43.80
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $86.54
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $153.95
Upside: -